Vagia, Elena
Cristofanilli, Massimo
Funding for this research was provided by:
Associazione per lo Sviluppo della Scienza Oncologica (ASSO), Siena, Italy
Article History
Accepted: 16 March 2021
First Online: 24 April 2021
Declarations
:
: Elena Vagia declares that she has no conflict of interest. Massimo Cristofanilli has received research funding from Eli Lilly, Pfizer, and G1 Therapeutics, and has received compensation for service as a consultant from CytoDyn, Eli Lilly, Pfizer, Sermonix, G1 Therapeutics, and Foundation Medicine.